Skip to main content
SpringerLink
Log in
Book cover

Molecular Basis of Thyroid Cancer pp 345–356Cite as

Past, Presence and Future of Thyroid-Stimulating Hormone (TSH) Superactive Analogs

  • Chapter

Part of the Cancer Treatment and Research book series (CTAR,volume 122)

Keywords

  • Thyroid Carcinoma
  • Papillary Thyroid Carcinoma
  • Differentiate Thyroid Carcinoma
  • Glycoprotein Hormone
  • Thyrotropin Receptor

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (Canada)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bozon V., Pajot-Augy E., Vignon, X., Salesse, R. (1998). “Endocytosis of lutropin by Leydig cells through a pathway distinct from the high-affinity receptor.” Mol Cell Endocrinol 143: 33–42.

    CrossRef  CAS  PubMed  Google Scholar 

  2. Cardin, A. D., Weintraub H.J. (1989). “Molecular modeling of protein-glycosaminoglycan interactions.” Arteriosclerosis 9: 21–32.

    CAS  PubMed  Google Scholar 

  3. Cole, E.S., K. Lee, Lauziere K., Kelton C., Chappel, S., Weintraub B., Ferrara, D., Peterson, P., Bernasconi, R., Edmunds, T. et al. (1993). “Recombinant human thyroid stimulating hormone: development of a biotechnology product for detection of metastatic lesions of thyroid carcinoma.” Biotechnology (N Y) 11: 1014–24.

    CrossRef  CAS  Google Scholar 

  4. Costagliola, S., Panneels, V., Bonomi, M., Koch, J., Many, M. C., Smits, G., Vassart, G. (2002). “Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors.” Embo J 21(4): 504–13.

    CrossRef  CAS  PubMed  Google Scholar 

  5. East-Palmer, J., Szkudlinski M.W., Lee, J., Thotakura, N. R., Weintraub, B. D. (1995). “A novel, nonradioactive in vivo bioassay of thyrotropin (TSH).” Thyroid 5: 55–9.

    CAS  PubMed  Google Scholar 

  6. Emerson, C.H., Torres M.S. (2003). “Recombinant human thyroid-stimulating hormone: pharmacology, clinical applications and potential uses.” Bio Drugs 17: 19–38.

    CAS  Google Scholar 

  7. Fairlie, W D., Stanton, P.G., Hearn M.T. (1996). “The disulphide bond structure of thyroid-stimulating hormone beta-subunit.” Biochem J 314: 449–55.

    CAS  PubMed  Google Scholar 

  8. Fang, Y., Lahiri, J., Picard L. (2003). “G protein-coupled receptor microarrays for drug discovery.” Drug Discov Today 8: 755–61.

    CrossRef  CAS  PubMed  Google Scholar 

  9. Grossmann, M., Szkudlinski, M. W., Wong, R., Dias, J. A., Ji, T. H., Weintraub, D. (1997). “Substitution of the seat-belt region of the thyrotropin (TSH)-ß subunit with the corresponding regions of choriogonadotropin or follitropin confers luteotropic, but not follitropic activity to chimeric TSH.” J Biol Chem 272: 15532–15540.

    CAS  PubMed  Google Scholar 

  10. Grossmann, M., Weintraub, B.D., Szkudlinski, M.W. (1997). “Novel insights into the molecular mechanisms of human thyrotropin action: structural, physiological and therapeutic implications for the glycoprotein hormone family.” Endocr Rev 18: 476–501.

    CrossRef  CAS  PubMed  Google Scholar 

  11. Grossmann, M., Leitolf, H., Weintraub, B.D., Szkudlinski, M.W. (1998). “A rational design strategy for protein hormone superagonists.” Nature Biotechnol 16: 871–5.

    CrossRef  CAS  Google Scholar 

  12. Gudermann, T., Kalkbrenner F., Schultz, G. (1996). “Diversity and selectivity of receptor-G protein interaction.” Annu Rev Pharmacol Toxicol 36: 429–59.

    CAS  PubMed  Google Scholar 

  13. Hearn, M. T. and P. T. Gomme (2000). “Molecular architecture and biorecognition processes of the cystine knot protein superfamily: part I. The glycoprotein hormones.” J Mol Recognit 13: 223–78.

    CrossRef  CAS  PubMed  Google Scholar 

  14. Heikoop, J.C., Huisman-de Winkel B., Grootenhuis, P.D. (1999). “Towards minimized gonadotropins with full bioactivity.” Eur J Biochem 261: 81–4

    CrossRef  CAS  PubMed  Google Scholar 

  15. Hsu, S. Y., Nakabayashi. K., Bhalla, A. (2002). “Evolution of glycoprotein hormone subunit genes in bilateral metazoa: identification of two novel human glycoprotein hormone subunit family genes, GPA2 and GPB5.” Mol Endocrinol 16: 1538–51.

    CrossRef  CAS  PubMed  Google Scholar 

  16. Kaczur, V., Puskas, L. G. Takacs, M., Racz, I. A., Szendroi, A., Toth, S., Nagy, Z., Szalai, C., Balazs, C, Falus, A., Knudsen B., Farid, N. R. (2003). “Evolution of the thyrotropin receptor: a G protein coupled receptor with an intrinsic capacity to dimerize.” Mol Genet Metab 78: 275–90.

    CrossRef  CAS  PubMed  Google Scholar 

  17. Kajava, A. V., Vassart, G., Wodak, S.J. (1995). “Modeling of the three-dimensional structure of proteins with the typical leucine-rich repeats.” Structure 3: 867–77.

    CrossRef  CAS  PubMed  Google Scholar 

  18. Kakinuma, A., Chazenbalk, G. D., Jaume. J. C., Rapoport, B., McLachlan, S. M. (1997). “The human thyrotropin (TSH) receptor in a TSH binding inhibition assay for TSH receptor autoantibodies.” J Clin Endocrinol Metab 82: 2129–34.

    CrossRef  CAS  PubMed  Google Scholar 

  19. Kenakin, T. (2003). “Predicting therapeutic value in the lead optimization phase of drug discovery.” Nat Rev Drug Discov 2: 429–38.

    CrossRef  CAS  PubMed  Google Scholar 

  20. Ladenson, P. W., Braverman, L.E., Mazzaferri, E., Brucker-Davis, F., Cooper, D.S., Garber, J.R., Wondisford, F.E., Davies, T.F, DeGroot, L.J., Daniels, G.H., Ross, D.S., Weintraub, B.D. (1997). “Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.” N Engl J Med 337: 888–930.

    CrossRef  CAS  PubMed  Google Scholar 

  21. Lapthorn, A.J., Harris, D. C., Littlejohn, A., Lustbader. J. W., Canfield, R. E., Machin, K.J., Morgan, F. J., Isaacs, N. W. (1994). “Crystal structure of human chorionic gonadotropin” Nature 369: 455–61.

    CrossRef  CAS  PubMed  Google Scholar 

  22. Leitolf, H., Tong, K. P., Grossmann, M., Weintraub, B. D., Szkudlinski, M. W. (2000). “Bioengineering of human thyrotropin superactive analogs by site-directed “lysine-scanning” mutagenesis. Cooperative effects between peripheral loops.” J Biol Chem 275: 27457–65.

    CAS  PubMed  Google Scholar 

  23. Marshall, S. A., Lazar, G. A., Chirino, A. J., Desjarlais, J. R. (2003). “Rational design and engineering of therapeutic proteins.” Drug Discov Today 8: 212–21.

    CrossRef  CAS  PubMed  Google Scholar 

  24. Meier, C. A., Braverman, L. E., Ebner, S. A., Veronikis, I., Daniels, G. H., Ross, D. S., Deraska, D. J., Davies, T. F., Valentine, M., DeGroot, L. J. et al., (1994). “Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study).” J Clin Endocrinol Metab 78: 188–96.

    CrossRef  CAS  PubMed  Google Scholar 

  25. Nakabayashi, K., Matsumi, H., Bhalla, A., Bae, J., Mosselman, S., Hsu, S. Y, Hsueh, A. J. (2002). “Thyrostimulin, a heterodimer of two new human glycoprotein hormone subunits, activates the thyroid-stimulating hormone receptor.” J Clin Invest 109: 1445–52.

    CrossRef  CAS  PubMed  Google Scholar 

  26. Pierce, J. G. and Parsons T.F. (1981). “Glycoprotein hormones: structure and function.” Annu Rev Biochem 50: 465–95.

    CrossRef  CAS  PubMed  Google Scholar 

  27. Rapoport B, Seto, P. (1985). “Bovine thyrotropin has a specific bioactivity 5-to 10-fold that of previous estimates for highly purified hormone.” Endocrinology 116: 1379–82.

    CAS  PubMed  Google Scholar 

  28. Rees Smith B., McLachlan S.M., Furmaniak J. (1988) Autoantibodies to the TSH receptor. Endocr Rev 9: 106–121

    CAS  PubMed  Google Scholar 

  29. Ribela, M. T, Bianco, A.C., Bartolini, P. (1996). “The use of recombinant human thyrotropin produced by Chinese hamster ovary cells for the preparation of immunoassay reagents.” J Clin Endocrinol Metab 81: 249–56.

    CrossRef  CAS  PubMed  Google Scholar 

  30. Ringel, M. D., Ladenson P.W. (1996). “Diagnostic accuracy of 1311 Scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypothyroidism.” J Clin Endocrinol Metab 81: 1724–1725.

    CrossRef  CAS  PubMed  Google Scholar 

  31. Robbins. R. J., Larson, S. M., Sinha, N., Shaha, A., Divgi, C., Pentlow, K. S., Ghossein, R., Tuttle, R. M. (2002). “A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation.” J Nucl Med 43: 1482–8.

    CAS  PubMed  Google Scholar 

  32. Rodien, P., Ho, S. C., Vlaeminck, V., Vassart, G., Costagliola, S. (2003). “Activating mutations of TSH receptor.” Ann Endocrinol (Paris) 64: 12–6.

    CAS  Google Scholar 

  33. Rommerts, F. F., van Loenen, H.J., Schipper, I., Fauser, B.C. (1992). “FSH-receptor interactions and signal transduction: an alternative view.” in “Follicle Stimulating Hormone: Regulation of Secretion and Molecular Mechanisms of Action.” The Proceedings of the Symposium On Regulation and Actions of Follicle Stimulating Hormone, October 25–28, 1990, Evanston, Illinois. Edited by M. Hunzicker-Dunn and N. B. Schwartz. Norwell, MA, Serono Symposia, USA: 61–81.

    Google Scholar 

  34. Smits, G., Campillo, M., Govaerts, C., Janssens, V., Richter, C. Vassart, G., Pardo, L. Costagliola, S. (2003). “Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity.” Embo J 22: 2692–703.

    CrossRef  CAS  PubMed  Google Scholar 

  35. Szkudlinski, M. W, Thotakura, N. R., Bucci, I., Joshi, L. R., Tsai, A., East-Palmer, J., Shiloach, J., Weintraub, B. D. (1993). “Purification and characterization of recombinant human thyrotrop in (TSH) isoforms produced by Chinese hamster ovary cells: the role of sialylation and sulfation in TSH bioactivity.” Endocrinology 133: 1490–503.

    CrossRef  CAS  PubMed  Google Scholar 

  36. Szkudlinski, M. W., Teh, N.G., Grossmann, M., Tropea, J.E., Weintraub, B.D. (1996). “Engineering human glycoprotein hormone superactive analogues.” Nature Biotechnol 14: 1257–63.

    CrossRef  CAS  Google Scholar 

  37. Szkudlinski, M. W., Grossmann, M., Weintraub, B.D. (1996). “Structure-function studies of human TSH: new advances in the design of glycoprotein hormone analogs.” Trends Endocrinol Metab 7: 277–286.

    CAS  Google Scholar 

  38. Szkudlinski, M., Teh, N.G., Grossmann, M., Tropea, J.E., Witta, J., Weintraub, B.D. (1996). “Role of the 40–51 region of the alpha-subunit in the bioactivity of human thyrotropin and gonadotropins: Implications for the design of new hormone analogs based on simultaneous mutagenesis of multiple domains.” 10th International Congress of Endocrinology, San Francisco, CA, June 12–15th, 1996 (Abstract #OR1-4).

    Google Scholar 

  39. Szkudlinski, M. W., Fremont, V., Ronin, C., Weintraub, B.D. (2002). “Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships.” Physiol Rev 82: 473–502.

    CAS  PubMed  Google Scholar 

  40. Utiger, R. D. (1997). “Follow-up of patients with thyroid carcinoma.” N Engl J Med 337: 928–30.

    CrossRef  CAS  PubMed  Google Scholar 

  41. Willey, K. P. (1999). “An elusive role for glycosylation in the structure and function of reproductive hormones.” Hum Reprod Update 5: 330–55.

    CrossRef  CAS  PubMed  Google Scholar 

  42. Wondisford, F. E., Usala, S. J., DeCherney, G. S., Castren, M., Radovick, S., Gyves, P. W., Trempe, J. P., Kerfoot, B. P., Nikodem, V. M., Carter, B. J. et al., (1988). “Cloning of the human thyrotropin beta-subunit gene and transient expression of biologically active human thyrotropin after gene transfection.” Mol Endocrinol 2: 32–9.

    CAS  PubMed  Google Scholar 

  43. Wonerow, P., Neumann, S., Gudermann, T, Paschke, R. (2001). “Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action.” J Mol Med 79: 707–21.

    CAS  PubMed  Google Scholar 

  44. Zhang, M., Tong, K. P., Fremont, V., Chen, J., Narayan, P., Puett, D., Weintraub, B. D., Szkudlinski, M. W. (2000). “The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design.” Endocrinology 141: 3514–7.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Trophogen, Inc., 6 Taft Court, Suite #150, Rockville, MD, 20850, USA

    Mariusz W. Szkudlinski

Authors
  1. Mariusz W. Szkudlinski
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Osancor Biotech, Inc., Watford, WD17 3BY, Herts, UK

    Nadir R. Farid

Rights and permissions

Reprints and Permissions

Copyright information

© 2005 Springer Science + Business Media, Inc.

About this chapter

Cite this chapter

Szkudlinski, M.W. (2005). Past, Presence and Future of Thyroid-Stimulating Hormone (TSH) Superactive Analogs. In: Farid, N.R. (eds) Molecular Basis of Thyroid Cancer. Cancer Treatment and Research, vol 122. Springer, Boston, MA. https://doi.org/10.1007/1-4020-8107-3_19

Download citation

  • DOI: https://doi.org/10.1007/1-4020-8107-3_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4020-8106-4

  • Online ISBN: 978-1-4020-8107-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

search

Navigation